[Federal Register Volume 81, Number 100 (Tuesday, May 24, 2016)]
[Notices]
[Page 32753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12224]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) and the Health Resources and Services Administration 
(HRSA) announce the following committee meeting.
    Times and Dates: 8:30 a.m.-5:30 p.m., EDT, June 14, 2016; 8:30 
a.m.-3:00 p.m., EDT, June 15, 2016.
    Place: CDC Corporate Square, Building 8, Conference Room 1-ABC, 8 
Corporate Boulevard, Atlanta, Georgia 30329, Telephone: (404) 639-8317. 
The meeting is also accessible by teleconference. Toll-free number +1 
(877) 603-4228, Participant code: 42598858.
    Status: Open to the public, limited only by the space available. 
The meeting room will accommodate approximately 100 people.
    Purpose: This Committee is charged with advising the Director, CDC 
and the Administrator, HRSA, regarding activities related to prevention 
and control of HIV/AIDS, Viral Hepatitis and other STDs, the support of 
health care services to persons living with HIV/AIDS, and education of 
health professionals and the public about HIV/AIDS, Viral Hepatitis and 
other STDs.
    Matters For Discussion: Agenda items include: (1) Syphilis among 
Men Who Have Sex with Men (MSM) and Congenital Syphilis; (2) Update on 
CDC's Medical Monitoring Project; (3) Discussion on Infectious Diseases 
prevention for people who inject drugs (PWID); (4) Findings of the 
Institute of Medicine Committee on A National Strategy for the 
Elimination of Hepatitis B and C: Feasible elimination goals and 
possible factors critical for success; and (5) Updates from Workgroups.
    Agenda items are subject to change as priorities dictate.
    Contact Person For More Information: Margie Scott-Cseh, CDC, 
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 
1600 Clifton Road NE., Mailstop E-07, Atlanta, Georgia 30333; telephone 
(404) 639-8317.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the CDC and the Agency for Toxic Substances and Disease 
Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 2016-12224 Filed 5-23-16; 8:45 am]
 BILLING CODE 4163-18-P